Dubai longevity conference puts AED 800-to-25,000 ageing packages under scrutiny

SpeedwayMedia.com published a 25 August 2026 article framing a Dubai longevity medicine conference around preventive medicine, diagnostics, genetics, regenerative care, nutrition and artificial intelligence, without naming an organiser, venue or event date.

That gap matters for UAE operators. The commercial signal is real, but the compliance burden sits with clinics, pharmacies and insurers. In Dubai, the relevant regulator is the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain it is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, the regulator is the Ministry of Health and Prevention (MOHAP).

What Dubai providers can sell now

Longevity medicine in Dubai is being packaged as preventive screening, biomarker review, nutrition, exercise medicine, sleep assessment and follow-up consultations. The public price points are already wide. Mediclinic lists a Dubai executive plus health package at AED 850. King's College Hospital London Dubai lists executive health checks at AED 4,450 to AED 6,800 and separate three-month longevity packages at AED 17,500 and AED 25,000.

Those numbers give CEOs and CFOs a usable range. A basic preventive check can sit below AED 1,000. A premium executive package can exceed AED 5,000. A branded longevity programme can move into five figures when it includes repeat visits, dietitian reviews, specialist consultations, laboratory testing and infusions.

The operational question is whether each component is licensed as medical care, wellness support, pharmacy dispensing or an aesthetic service. DHA's Health Facility Guidelines set planning and design expectations for Dubai facilities. MOHAP's registered medical product directory lets providers and patients search registered medicines and medical products. A pharmacy that sells supplements, hormone products or injectables beside a longevity clinic needs that product-level check before marketing claims are written.

What insurers and patients will ask

The payer position is uneven. In Abu Dhabi, Thiqa members aged 18 to 75 are eligible for IFHAS, a periodic screening programme usually offered every three years, or more often when a doctor decides it is needed. Daman administers major Abu Dhabi health plans, while Thiqa is the government programme for eligible UAE nationals in Abu Dhabi.

In Dubai, operators should assume that most longevity packages are cash-pay unless the insurer confirms a benefit in writing. Sukoon Global Health lists health-screening limits by plan tier, including $420, $850, $1,700 and $8,500 per policy year on its international individual and family plans. That is useful for plan design discussions, but it is not a blanket approval for every Dubai longevity package.

• Clinics should ask the insurer whether screening, genetic testing, dietitian visits, infusions and follow-up reviews are covered as separate benefits.
• Pharmacies should confirm whether prescribed medicines, supplements and devices sit under pharmacy, outpatient or exclusion rules.
• Patients should ask for the CPT, service code or insurer pre-approval pathway before paying for a package.
• Medical directors should document the clinical indication for each test, especially when repeating biomarkers every three to 12 months.

What operators should verify next

The SpeedwayMedia.com article describes a broad agenda for longevity conferences: aging biology, regenerative medicine, metabolic health, exercise science, wearables and AI. It does not provide speaker names, accreditation, CME status, sponsor details or a clinical protocol. Those omissions limit how far a UAE clinic can use the article as evidence for a new service line.

For COOs, the next step is a licence map. A Dubai clinic should check DHA scope approvals for internal medicine, family medicine, endocrinology, dietetics, laboratory collection, IV therapy and any regenerative procedure. An Abu Dhabi provider should check DOH facility and professional scope. A northern emirates operator should check MOHAP facility licensing, professional licensing and product registration before advertising longevity medicine.

For CFOs, the next step is a cash-flow model built around utilisation rather than conference interest. A clinic selling an AED 850 check needs volume, tight lab costs and short physician time. A clinic selling a three-month AED 17,500 package needs retention, repeat visits, informed consent and complaint handling. The financial risk rises when the package includes tests or products that an insurer later rejects.

Patients will still follow the promise of healthy ageing. UAE providers should follow the licence, the evidence and the payer rule. For pharmacy access, chronic refills and licensed pharmacy providers, readers can use the UAE Open Healthcare Directory and filter by emirate, insurance and provider type before referring a patient or building a pharmacy partnership.